NewAmsterdam Pharma Company NV [NAMS] stock prices are up 1.28% to $23.80 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The NAMS shares have gain 13.33% over the last week, with a monthly amount glided 13.06%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
NewAmsterdam Pharma Company NV [NASDAQ: NAMS] stock has seen the most recent analyst activity on December 30, 2024, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $48. On March 14, 2024, Scotiabank initiated with a Sector Outperform rating and assigned a price target of $35 on the stock. Guggenheim started tracking the stock assigning a Buy rating and suggested a price target of $30 on January 18, 2024. Piper Sandler initiated its recommendation with a Overweight and recommended $37 as its price target on January 16, 2024. RBC Capital Mkts started tracking with a Outperform rating for this stock on October 30, 2023, and assigned it a price target of $25.
The stock price of NewAmsterdam Pharma Company NV [NAMS] has been fluctuating between $15.19 and $27.29 over the past year. Currently, Wall Street analysts expect the stock to reach $43.33 within the next 12 months. NewAmsterdam Pharma Company NV [NASDAQ: NAMS] shares were valued at $23.80 at the most recent close of the market. An investor can expect a potential return of 82.06% based on the average NAMS price forecast.
Analyzing the NAMS fundamentals
Gross Profit Margin for this corporation currently stands at 1.0% with Operating Profit Margin at -3.71%, Pretax Profit Margin comes in at -5.12%, and Net Profit Margin reading is -5.12%. To continue investigating profitability, this company’s Return on Assets is posted at -0.27, Equity is -0.5 and Total Capital is -0.22. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 23.00 points at the first support level, and at 22.19 for the second support level. However, for the 1st resistance point, the stock is sitting at 24.42, and for the 2nd resistance point, it is at 25.03.
Ratios To Look Out For
It’s worth pointing out that NewAmsterdam Pharma Company NV [NASDAQ:NAMS]’s Current Ratio is 8.08. Further, the Quick Ratio stands at 8.08, while the Cash Ratio is 7.22. Considering the valuation of this stock, the price to sales ratio is 57.37, the price to book ratio is 3.40.
Transactions by insiders
Recent insider trading involved Topper James N, Director, that happened on Mar 04 ’25 when 4005.0 shares were purchased. Chief Accounting Officer, Kooij Louise Frederika completed a deal on Mar 04 ’25 to sell 0.15 million shares. Meanwhile, Officer Kooij Louise Frederika bought 0.15 million shares on Mar 04 ’25.
